Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05147584 · ClinicalTrials.gov registry record · NA
Trans-abdominal Fetal Pulse Oximetry
A NA study, sponsored by Raydiant Oximetry.
- Terminated
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05147584: Clinical Trial NA study, sponsored by Raydiant Oximetry.
NCT05147584 is a NA study that was terminated before completion, run by Raydiant Oximetry. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05147584, a NA study, was terminated before completion, sponsored by Raydiant Oximetry.
- TERMINATED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The Raydiant Oximetry Sensing System (Lumerah) is a non-invasive fetal pulse oximeter that measures fetal arterial oxygen saturation using safe, non-invasive, transabdominal near-infrared spectroscopy. Lumerah is intended as an adjunct to cardiotocography by detecting decreases in fetal oxygenation.
Interventions
- DEVICE Dual fetal oxygen sensors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-07-20 |
| Est. Completion | 2023-11-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05147584
The ClinicalTrials.gov registry entry for NCT05147584 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Raydiant Oximetry, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dual fetal oxygen sensors is the first listed.
NCT05147584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05147584 about?
NCT05147584 is a clinical study titled "Trans-abdominal Fetal Pulse Oximetry". The Raydiant Oximetry Sensing System (Lumerah) is a non-invasive fetal pulse oximeter that measures fetal arterial oxygen saturation using safe, non-invasive, transabdominal near-infrared spectroscopy. Lumerah is intended as an adjunct to cardiotocography by detecting decreases in fetal oxygenation.
What is the current status of trial NCT05147584?
This trial is currently terminated. It is a NA study. The enrollment target is 31 participants. The study started on 2022-07-20. Estimated completion is 2023-11-29.
What interventions are being tested in trial NCT05147584?
The interventions under investigation include: Dual fetal oxygen sensors (DEVICE).
Who is sponsoring clinical trial NCT05147584?
This trial is sponsored by Raydiant Oximetry, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.